PDCI’s Market Access Toolkit includes industry leading resources to support prescription medicine manufacturers in the development and execution of market access strategies for the Canadian market including:
Census of Insurers
The PDCI Census of Insurers is a unique resource exploring Canadian private covered lives by insurer by province and plan types:
Model how public listings can affect private coverage and access
Plan and forecast private coverage for product portfolios
Test time to listing scenarios for products
Educate and inform sales teams about regional differences in coverage and access
INSIGHTS Journal
Our mission for INSIGHTS is to provide thought leadership through analysis and informed opinion to support our clients in maintaining a strong understanding of private trends to gain optimal access in the private market.
The private market pays for four out of every ten dollars spent on prescription drugs by Canadians; Covering more medicines than their public sector counterparts, the private market is concentrated, regional and with a few dominant players. Because it is difficult for clients to stay current, we dedicate resources to provide that analytical support.
Product Reimbursement and Insurance Market Evaluation (PRIME) Reports
PDCI incorporates disease specific TCP’s from the CHRIS model to provide detailed Product specific Reimbursement and Insurance Market Evaluations (PRIME) coverage reports which provide:
Product Coverage insights such as:
Summary of private and public coverage
National and Provincial breakdowns
Regional insurer coverage status breakdowns
Insured population demographics.
The Canadian Health Reimbursement and Insurance Simulation (CHRIS) Model
Canadian reimbursement is constantly changing. Canada’s ten provinces each have unique policies and reimbursement programs available for their residents. The CHRIS model explores public programs and how they coordinate benefits with private forms of reimbursement.
CHRIS’ detailed breakdown of patient access to private and public insurance for pharmaceutical products in Canada supports reimbursement strategies for the launch and ongoing management of reimbursement of health products in Canada.
Epidemiology:
Using disease specific prevalence or incidence data, develop disease specific Therapeutic Coverage Profiles (TCPs).
Insurance Coverage:
National and provincial insurance profiles based on population data
Explore potential overlap of private and public insurance and benefit coordination
Public Private Split eligibility estimates
Age and provincial coverage profiles
Additional Tools and Models:
TCPs inform PDCI’s Product Reimbursement and Insurance Market Evaluation (PRIME)
Ask us how we can leverage TCP’s for additional applications including Product Coverage Ramps and Patient Support Program Simulation Models and other forecasting tools.
Custom Private Market Claims Analysis
Ask about our capabilities to analyze and explore deidentified patient level data to characterize product specific reimbursement journeys.
